A study of PRA023 in patients with Systemic Sclerosis Associated with Interstitial Lung Disease
A Double Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PRA023 in Subjects with Systemic Sclerosis Associated with Interstitial Lung Disease (SSc-ILD) - The ATHENA-SSc-ILD Study A Double Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PRA023 i ...
Systemic sclerosis associated with interstitial lung disease MedDRA version: 21.0;Level: LLT;Classification code 10025109;Term: Lung involvement in systemic sclerosis;System Organ Class: 100000004855;Therapeutic area: Diseases [C] - Immune System Diseases [C20] Systemic sclerosis associated with interstitial lung disease MedDRA version: 21.0;Level: LLT;Classif ...
Product Code: PRA023 INN or Proposed INN: tulisokibart Other descriptive name: PRA023
Prometheus Biosciences, Inc.
NULL
Authorised-recruitment may be ongoing or finished
Female: yes Male: yes
100
Phase 2
United States;Spain;Israel;United Kingdom;Switzerland;Italy;France;Hungary;Canada;Poland;Belgium;Australia;Norway;Germany;Netherlands United States;Spain;Israel;United Kingdom;Switzerland;Italy;France;Hungary;Canada;Poland;Belgium;Aus ...